Market Restraints
Plummeting costs of caprolactam due to increasing production capacity and oversupply is expected to be the key challenge for caprolactam market. As a result, from 2020 continuous caprolactam production capacity reduction are taking place to provide stability in supply and price. On September 12, 2020, BASF SE announced plans to reduce caprolactam production at its Ludwigshafen plant by 100,000 MT over the following 18 months. Moreover, DSM Chemicals ceased operations at its caprolactam plant in the U.S. by the end of 2020. Furthermore, according to Coherent Market Insights analysis, due to continuous oversupply of caprolactam by China, some existing caprolactam production plants are expected to shut down during the forecast period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients